New brominated and halogen-less derivatives and structure-activity relationship of azaphilones inhibiting gp120-CD4 binding

Journal of Antibiotics

Volumn 51, Issue 11, 1998, Pages 1004-1011

  Matsuzaki, Keiichi ^a   Tahara, Harumi ^a   Inokoshi, Junji ^a   Tanaka, Haruo ^a   Masuma, Rokuro ^b   Omura, Satoshi ^b  

^a KITASATO UNIVERSITY   (Japan)

^b KITASATO INSTITUTE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

AZAPHILONE DERIVATIVE; BROMINE; CD4 ANTIGEN; GLYCOPROTEIN GP 120; NEW DRUG; POTASSIUM BROMIDE; UNCLASSIFIED DRUG;

ARTICLE; PENICILLIUM; PRIORITY JOURNAL; STRUCTURE ACTIVITY RELATION;

EID: 0031729820     PISSN: 00218820     EISSN: None     Source Type: Journal    
DOI: 10.7164/antibiotics.51.1004     Document Type: Article

References (17)

1. TAKAHASHI, M.; K. KOYAMA & S. NATORI: Four new azaphilones from Chaetomium globosum var. flavoviridae. Chem. Pharm. Bull. 38: 625-628, 1990
2. ŌMURA, S.; H. TANAKA, K. MATSUZAKI, H. IKEDA & R. MASUMA: Isochromophilones I and II, novel inhibitors against gp120-CD4 binding from Penicillium sp. J. Antibiotics 46: 1908-1911, 1993
3. MATSUZAKI, K.; H. IKEDA, H. TANAKA, R. MASUMA & S. ŌMURA: Isochromophilones I and II, novel inhibitors against gp120-CD4 binding produced by Penicillium multicolor FO-2338. I. Screening, taxonomy, fermentation, isolation and biological activity. J. Antibiotics 48: 703-707, 1995
4. MATSUZAKI, K.; S. ŌMURA & H. TANAKA: Isochromophilones I and II, novel inhibitors against gp120-CD4 binding produced by Penicillium multicolor FO-2338. II. Structure elucidation. J. Antibiotics 48: 708-713, 1995
5. 13C coupling in structural and biosynthetic studies. III. Ochrephilone-a new fungal metabolite. Tetrahedron Lett. 651-654, 1974
6. 5Cl, a chlorine-containing metabolic product of Penicillium sderotionim Van Beyma. Biochem. J. 34: 1419-1421, 1940
7. PAIRET, L.; S. K. WRIGLEY, I. CHETLAND, E. E. REYNOLDS, M. A. HYES, J. HOLLOWAY, A. M. AINSWORTH, W. KATZER, X.-M. CHENG, D. J. HUPE, P. CHARLTON & A. M. DOHERTY: Azaphilones with endothelin receptor binding activity produced by Penicillium sclerotiorum: Taxonomy, fermentation, isolation, structure elucidation and biological activity. J. Antibiotics 48: 913-923, 1995
8. CHONG, R.; R. R. KING & W. B. WHALLEY: The synthesis of sclerotiorin and of an analogue of rotiorin. J. Chem. Soc. Chem. Commun. 1512-1513, 1969
9. CHONG, R.; R. R. KING & W. B. WHALLEY: The chemistry of fungi. Part LXI. The synthesis of (±)-sclerotiorin, of (±)-4,6-dimethylocta-trans-2, trans-4-dienoic acid, and an analogue of rotiorin. J. Chem. Soc. (C) 3566-3571, 1971
10. STEYN, P. S. & R. VLEGGAAR: The structure of dihydroxy-8-epi-austdiol and the absolute configuration of the azaphilones. J. Chem. Soc. Perkin I, 204-206, 1976
11. FUJIMOTO, H.; T. MATSUDO, A. YAMAGUCHI & M. YAMAZAKI: Two new fungal azaphilones from Talaromyces luteus, with monoamine oxidase inhibitory effect. Heterocycles 30: 607-616, 1990
12. ARAI, N.; K. SHIOMI, H. TOMODA, N. TABATA, D.-J. YANG, R. MASUMA, T. KAWAKUBO & S. ŌMURA: Isochromophilones III-VI, inhibitors of acyl-CoA: cholesterol acyltransferase produced by Penicillium multicolor FO-3216. J. Antibiotics 48: 696-702, 1995
13. NATSUME, M.; Y. TAKAHASHI & S. MARUMO: Chlamydospore-like cell-inducing substances of fungi: Close correlation between chemical reactivity with methylamine and biological activity. Agric. Biol. Chem. 52: 307-312, 1988
14. SATOH, Y. & M. YAMAZAKI: Studies on the monoamine oxidase (MAO) inhibitory potency of TL-1, isolated from a fungus, Talaromyces luteus. Chem. Pharm. Bull. 37: 206-207, 1989
15. YOSHIDA, E.; H. FUJIMOTO & M. YAMAZAKI: Isolation of three new azaphilones, luteusins C, D, and E, from as ascomycete, Talaromyces luteus. Chem. Pharm. Bull. 44: 284-287, 1996
16. YASUKAWA, K.; M. TAKAHASHI, S. NATORI, K. KAWAI, M. YAMAZAKI, M. TAKEUCHI & M. TAKIDO: Azaphilones inhibit tumor promotion by 12-O-tetradecanoylphorbol-13-acetate in two-stage carcinogenesis in mice. Oncology 51: 108-112, 1994
17. 2 inhibitors containing sclerotiorin from Penicillium sderotionim for treatment of inflammatory pancreatitis, and allergy. JP 02255615 A2, October 16, 1990